Cargando…
Valorization of clinical trials from the Italian National Health Service perspective: definition and first application of a model to estimate avoided costs
INTRODUCTION: From the perspective of healthcare organizations and public health care systems, the value of a clinical trial can be assessed from a clinical and economical perspective. However, to date, there is no standardized model for systematically capturing the economic value of clinical trials...
Autores principales: | Cicchetti, Americo, Addesso, Domenico, Leone, Filippo E., Amato, Antonino, Angerame, Luca, D’Aversa, Angelo, Fraticelli, Mario, Nicora, Carlo, Sfreddo, Eleonora, Fumarola, Mariangela, Porcino, Roberta, Cocciolo, Gabriella, Re, Simona, Scaccabarozzi, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AboutScience
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677598/ https://www.ncbi.nlm.nih.gov/pubmed/36627963 http://dx.doi.org/10.33393/grhta.2020.709 |
Ejemplares similares
-
Avoiding Common Writing Mistakes That Make Your Editors and Reviewers Cringe
por: Porcino, Antony, et al.
Publicado: (2015) -
UPF1 silenced cellular model systems for screening of read-through agents active on β(0)39 thalassemia point mutation
por: Salvatori, Francesca, et al.
Publicado: (2018) -
Towards new definitions of avoidable hospital admissions
por: Booker, Matthew, et al.
Publicado: (2022) -
Impact of SARS-CoV-2 on Provided Healthcare. Evidence From the Emergency Phase in Italy
por: Di Bidino, Rossella, et al.
Publicado: (2020) -
Screening Readthrough Compounds to Suppress Nonsense Mutations: Possible Application to β-Thalassemia
por: Borgatti, Monica, et al.
Publicado: (2020)